Condition 1: Atherosclerosis. Condition 2: Obstructive and urinary tract symptoms. Atherosclerosis Obstructive and reflux uropathy, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Treatment with tamsulosin 0.4 mg daily one alone- (Trade names, Flomax, others )- Patients before treatment, 4, 8 and 12 weeks after starting treatment (PVR, IPSS,
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: Male patients referred to urology clinic with obstructive and urinary tract symptoms for at least 6 months Patients over 50 years of age
Exclusion criteria
Exclusion criteria: Male patients referred to urology clinic less than 50 years old PSA higher than 10 Urine residue 300ml or higher determined by ultrasound Receiving Finasteride during the last 3 months Receiving anti-androgen drugs History of pelvic surgery or radiotherapy History of lower urinary tract malignancy Lower urinary tract trauma Urinary retention Bladder stones Urinary tract infection that is determined by urine culture Urethral stricture Neurological disease affecting bladder function Secondary obstruction to the median lobe of the prostate Prostate cancer Liver or kidney failure Cardiovascular diseases such as significant angina that need to be checked by a cardiologist and CHF not compensated, recent MI and uncontrolled blood pressure treatment with nitrates Uncontrolled diabetes HbAlc> 9%
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment of obstructive and urinary tract symptoms. Timepoint: At one month intervals for three months. Method of measurement: Q max evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Akram Mirzaei
Tehran University of Medical Sciences
Outcome results
None listed